ATLANTA--(BUSINESS WIRE)--US-based medical device company and producer of the NaturalVue® (etafilcon A) Multifocal 1 Day Contact Lenses Visioneering Technologies, Inc. (ASX: VTI) (‘Visioneering’ or ‘The Company’) announces the creation of a new educational series for eye care practitioners featuring some of the world’s leading researchers and clinicians. The first installment of the VTI / NaturalVue video series highlights the following speakers and topics: Prof Earl Smith, Researcher, Universi

Full Story →

ATLANTA--(BUSINESS WIRE)--US-based medical device company and producer of the NaturalVue® (etafilcon A) Multifocal 1 Day Contact Lenses Visioneering Technologies, Inc. (ASX: VTI) (‘Visioneering’ or ‘The Company’) announces the creation of a new educational series for eye care practitioners featuring some of the world’s leading researchers and clinicians. The first installment of the VTI / NaturalVue video series highlights the following speakers and topics: Prof Earl Smith, Researcher, Universi

Full Story →